| Literature DB >> 27365375 |
Ulrich H Weidle1, Fabian Birzele2, Gwendlyn Kollmorgen1, Rüdiger Rüger3.
Abstract
Brain metastases outnumber the incidence of brain tumors by a factor of ten. Patients with brain metastases have a dismal prognosis and current treatment modalities achieve only a modest clinical benefit. We discuss the process of brain metastasis with respect to mechanisms and involved targets to outline options for therapeutic intervention and focus on breast and lung cancer, as well as melanoma. We describe the process of penetration of the blood-brain-barrier (BBB) by disseminated tumor cells, establishment of a metastatic niche, colonization and outgrowth in the brain parenchyma. Furthermore, the role of angiogenesis in colonization of the brain parenchyma, interactions of extravasated tumor cells with microglia and astrocytes, as well as their propensity for neuromimicry, is discussed. We outline targets suitable for prevention of metastasis and summarize targets suitable for treatment of established brain metastases. Finally, we highlight the implications of findings revealing druggable mutations in brain metastases that cannot be identified in matching primary tumors. CopyrightEntities:
Keywords: Angiogenesis; astrocytes; biomarkers for brain metastasis; blood-brain-barrier; brain parenchyma; genetics of brain metastasis; microglia; neuromimicry; review; transmigration
Mesh:
Substances:
Year: 2016 PMID: 27365375
Source DB: PubMed Journal: Cancer Genomics Proteomics ISSN: 1109-6535 Impact factor: 4.069